Reaction
Pyelocaliectasis reporting signals
As of the last recalculation, Pyelocaliectasis appears in 919 FAERS reports alongside 18 co-occurring drug terms. The strongest observed disproportionality signal is DARUNAVIR (PRR 43.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Darunavir | 28 | 43.2 | 43.3 |
| Fondaparinux Sodium | 14 | 39.8 | 39.8 |
| Ritonavir | 46 | 37.5 | 37.5 |
| Lopinavir And Ritonavir | 20 | 34.1 | 34.2 |
| Ritonavir 100 Mg | 19 | 29.4 | 29.4 |
| Asfotase Alfa | 10 | 22.8 | 22.9 |
| Lamivudine | 28 | 21.1 | 21.2 |
| Raltegravir | 14 | 19.5 | 19.5 |
| Lamivudine Oral | 21 | 19.2 | 19.2 |
| Atazanavir | 11 | 17.5 | 17.5 |
| Insulin Glargine-Yfgn | 15 | 15.8 | 15.8 |
| Norepinephrine | 7 | 14.9 | 14.9 |
| Norepinephrine Bitartrate | 9 | 14.3 | 14.3 |
| Ifosfamide | 12 | 12.8 | 12.8 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 21 | 10.6 | 10.7 |
| Brinzolamide | 4 | 10.5 | 10.5 |
| Polatuzumab Vedotin | 3 | 7.0 | 7.0 |
| Emtricitabine And Tenofovir Alafenamide | 3 | 6.0 | 6.0 |